Regulators in the EU, China, and Japan have started reviews of GSK's depemokimab, aiming to become the first drug for severe asthma that can be given just twice a year. The EMA and counterparts in ...
Abstract: With the ever-growing complexity of digital circuits, the appeal of using Machine Learning in digital circuit design has grown significantly. Over the last 25 years, Evolutionary Algorithms ...
Abstract: With the growing demand for clean and safe drinking water, there is a need for innovative approaches to enhance water access and distribution, particularly in public places like railway ...